Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In 1999, a provocative letter was published in your journal1 concerning the use of d-penicillamine (DPA) in the neonatal period. The following statement was written: “Why, then, we wonder, has the demonstration of an effective mode of prevention of retinopathy of prematurity (ROP) in two randomised trials conducted more than 10 years ago in Hungary,2 failed to encourage others to undertake the independent replications needed to verify or refute such a promising approach?”
Now, we …
Competing interests: None declared.